How Much Does Semaglutide Cost?

No — no FDA-approved generic semaglutide exists, so an advertised "generic semaglutide price" is describing something else. The core patent runs to roughly 2031, with formulation and device patents extending exclusivity further; a generic becomes possible only once those lapse and a manufacturer files and wins approval. Products marketed as "generic" today are compounded semaglutide, which is a separate category — a generic is an FDA-approved equivalent, a compounded preparation has had no FDA review of its safety, quality or consistency. Cheaper, yes; a generic, no.

It depends entirely on the route. Brand Ozempic and Wegovy carry list (WAC) prices of about $969–$998/mo and $1,349/mo respectively before insurance. NovoCare self-pay brings injectable Wegovy to about 349/month for maintenance doses (199/month introductory), the oral Wegovy pill starts around 149/month, and compounded semaglutide runs $69–$300/mo — though compounded is not FDA-approved as a finished drug. With commercial insurance and a manufacturer savings card, brand copays can drop to as low as $0–$25/month. Prices as of July 2026.

Because "semaglutide" spans several products at very different price points: FDA-approved brands (Ozempic, Wegovy, Rybelsus, and the oral Wegovy pill) sold at high list prices but often discounted by insurance or manufacturer self-pay programs, versus compounded semaglutide made by pharmacies. The molecule is the same active ingredient, but FDA-approval status, dose form, and who is selling it drive the price.

Often yes on sticker price — compounded semaglutide via telehealth runs about $69–$300/mo, below brand list prices. But it is not FDA-approved as a finished product, quality varies by pharmacy, and the "all-in" cost includes any visit or membership fee. Compare the total monthly cost, not just the medication price, and verify the pharmacy is a licensed US 503A/503B before buying.

Coverage is plan-specific. Commercial plans commonly cover Ozempic for type 2 diabetes (with prior authorization) and increasingly cover Wegovy for weight management, though self-funded employer plans often exclude weight-loss drugs. Medicare covers semaglutide for approved medical indications (like diabetes or cardiovascular risk reduction) but not for weight loss alone. Check your formulary and see our payer-by-payer coverage pages.

For most people the cheapest FDA-approved route is the oral Wegovy pill from about $149/month or NovoCare self-pay from ~$199–$349/month; with commercial insurance a savings card can bring the copay to $0–$25. Compounded semaglutide can be lower but is not FDA-approved. See our full cheapest-semaglutide breakdown for the route-by-route ranking.